Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

ClinicalTrials.gov ID: NCT03131154

Public ClinicalTrials.gov record NCT03131154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-masked, Vehicle-controlled Trial to Evaluate the Safety and Efficacy of ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis.

Study identification

NCT ID
NCT03131154
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aldeyra Therapeutics, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • ADX-102 Ophthalmic Solution (0.5%) Drug
  • Vehicle of ADX-102 Ophthalmic Solution Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 25, 2017
Primary completion
Apr 18, 2019
Completion
Apr 25, 2019
Last update posted
Feb 9, 2025

2017 – 2019

United States locations

U.S. sites
27
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
UAB Department of Ophthalmology Birmingham Alabama 35233
Retinal Research Institute Phoenix Arizona 85014
M&M Eye Institute Prescott Arizona 86301
Walman Eye Center Sun City Arizona 85351
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
University of California, Irvine Irvine California 92697
Byers Eye Institute at Stanford University Palo Alto California 85014
Retinal Consultants Medical Group, Inc. Sacramento California 95819
Corneal Consultants of Colorado Littleton Colorado 80120
Danbury Eye Physicians & Surgeons Danbury Connecticut 06810
Levenson Eye Associates Jacksonville Florida 33204
Center for Retina and Macular Disease Winter Haven Florida 33880
Midwest Eye Institute Indianapolis Indiana 46290
John Hopkins Baltimore Maryland 21205
Valley Eye Physicians & Surgeons Ayer Massachusetts 01432
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Ocular Immunology & Uveitis Foundation Waltham Massachusetts 02451
Oakland Ophthalmic Surgery Birmingham Michigan 48009
Tauber Eye Center Kansas City Missouri 64111
Metropolitan Eye Research and Surgery Institute Palisades Park New Jersey 07650
Bergstrom Eye Research Fargo North Dakota 58103
Oregon Retina, LLP Eugene Oregon 97401
Texas Retina Associates Dallas Texas 75231
Retina Consultants of Houston Houston Texas 77030
Retina and Uveitis Consultants of Texas San Antonio Texas 78240
Retina Consultants of Houston The Woodlands Texas 77384
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03131154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03131154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →